Etid klinik pou VIH nan Distrik Columbia
9 etid pou VIH ap chèche patisipan nan sit nan Distrik Columbia.
Vil nan Distrik Columbia
Tèks ofisyèl etid la (Anglè)
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Washington D.C.
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07650916El Camino HIV Prevention and Care Study
- La Clínica del Pueblo, Washington D.C.
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 22, 2026 · NCT07834853A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Whitman-Walker Institute ( Site 1538), Washington D.C.
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07266831Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
- George Washington University, Washington D.C.
Ap rekrite
Laj 45 a 80 · Tout sèks · Mizajou Aug 19, 2026 · NCT04949464Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- George Washington University, Washington D.C.
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT05663502The DC Cohort Longitudinal HIV Status Neutral Study
- Kaiser Permanente Mid-Atlantic States, Washington D.C.
- Unity Health Care, Washington D.C.
- Georgetown University, Washington D.C.
- ak 11 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Feb 2, 2026 · NCT01206920Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)
- HIPS (Harm reduction drop-in center), Washington D.C.
Ap rekriteVolontè an sante akeyi
Laj 18 a 88 · Tout sèks · Mizajou Oct 31, 2025 · NCT06501781Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
- GSK Investigational Site, Washington D.C.
Ap rekriteFaz 1/2
Laj 6 a 12 · Tout sèks · Mizajou Sep 19, 2024 · NCT05674656Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
- Whitman-Walker Health, Washington D.C.
Ap rekriteVolontè an sante akeyi
Laj 15 ak plis · Tout sèks · Mizajou Sep 28, 2022 · NCT04855773Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.